Congo-Crimean Hemorrhagic Fever
Congo-Crimean Hemorrhagic Fever (CCHF) is a viral infection transmitted by ticks, characterized by fever, muscle pain, and bleeding. It can lead to severe complications and requires prompt medical attention.
Crimean Congo Hemorrhagic Fever: N-pVAX1 Vaccine Study
We are evaluating a new DNA vaccine to see if it is safe and can help the body fight against Crimean Congo Hemorrhagic Fever. This study is for healthy volunteers who want to contribute to vaccine research.
Safety phase (I)Infectious Diseases
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Karolinska University Hospital
Dept. of Infectious Diseases
Huddinge, Sweden
Sponsor: Karolinska Institutet
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.